Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.
This study will compare morphine consumption during the first 48 hours postoperatively between the OFA group and the CA control group.
Breast Cancer
DRUG: Dexmedetomidine
comparison of Morphine consumption in the two groups, during the first 48 hours postoperatively
Assessment of vasopressor requirement and total intraoperative filling volume, end of surgery|Assessment of the state of consciousness on arrival in the PACU, on arrival in the PACU|Assessment of the incidence of PONV in the PACU, at D0, D1 and D2, in the PACU, at D0, D1 and D2|Maximum VAS at rest and mobilization in the PACU, at D0, D1 and D2, in the PACU, at D0, D1 and D2|Dose of morphine given in titration in the PACU (mg), in the PACU|Number of boluses demand on PCA during the first 48 hours postoperatively, the first 48 hours postoperatively|DN3 score (Neuropathic Pain 3) on D2, D4, M1, M3 and M6, on D2, D4, M1, M3 and M6|Length of stay in PACU (h) and length of in-hospital postoperative length of stay (D), at discharge|Assessment of the flap failure rate (flap removal surgery) and flap micro-anastomosis re-exploration rate, at discharge|Pain management satisfaction scores (score from 0 to 10) at discharge, at discharge|Collection of serious adverse events between D0 (date of surgery) and D30, between D0 (date of surgery) and D30|Dose of intraoperative rescue remifentanil in the OFA group (mcg), at discharge|Morphine consumption during the first 48 hours post-operatively (mg) in each breast reconstruction subgroup (immediate and secondary);, the first 48 hours postoperatively
This study will compare morphine consumption during the first 48 hours postoperatively between the OFA group and the CA control group.